Long-term safety look-back for ProVee device users
Part of Kidney & urinary clinical trials.
This study analyzes data from people who had the ProVee device removed after previous studies. It aims to understand long-term outcomes and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were part of the ProVIDE Study or the ProVIDE II Bridging Study.
- You had the ProVee device removed.
- You withdrew from, or were withdrawn by the study doctor from, one of those studies.
- You gave permission for your study data to be used.
- You did not restart BPH medicine while in the earlier study.
- You did not leave the earlier study because of prostate cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device (Vivifi) that aims to treat an enlarged prostate without surgery. The goal is to improve urine flow and reduce symptoms like frequent or weak urination.
This trial compares two minimally invasive procedures to relieve urinary symptoms caused by an enlarged prostate. Both treatments aim to open the urethra without major surgery, and the goal is to improve your urine flow and reduce bothersome symptoms.
This study follows men who have urine leakage from stress (leakage with movement/coughing) after prostate surgery and receive a ProACT device. It looks at long-term outcomes over 5 years and checks safety, including for those who may need device removal or other treatments.
This study collects information from men who are having a minimally invasive procedure for an enlarged prostate. It helps doctors learn more about how well these treatments work and how they affect your quality of life.
This trial tests a new treatment for enlarged prostate (BPH) that targets veins in the scrotum to improve urinary symptoms. It may be an option if you have both BPH and a varicocele and haven't had prior prostate surgery.
This trial tests a new minimally invasive treatment device called the ALPFA GRAIL System to see if it safely and effectively reduces urinary symptoms caused by an enlarged prostate. The procedure aims to improve urinary flow and reduce bothersome symptoms like frequent urination.
Hear when a new BPH With Symptomatic Lower Urinary Tract Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.